These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 11352850

  • 1. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF, Hsing AW.
    Cancer Res; 2001 Jun 01; 61(11):4333-6. PubMed ID: 11389055
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factors and risk of benign prostatic hyperplasia.
    Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni JF, Hsing AW.
    Prostate; 2002 Jul 01; 52(2):98-105. PubMed ID: 12111701
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug 01; 11(8):705-12. PubMed ID: 12163322
    [Abstract] [Full Text] [Related]

  • 5. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 01; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 01; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 7. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 8. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun 15; 15(6):1137-41. PubMed ID: 16775172
    [Abstract] [Full Text] [Related]

  • 9. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R.
    J Clin Oncol; 2004 Aug 01; 22(15):3104-12. PubMed ID: 15284261
    [Abstract] [Full Text] [Related]

  • 14. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 01; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factors and their binding proteins in children with IDDM.
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S.
    J Med Assoc Thai; 2002 Jan 01; 85(1):41-52. PubMed ID: 12075719
    [Abstract] [Full Text] [Related]

  • 16. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 01; 13(8):1290-5. PubMed ID: 15298948
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun 01; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.
    Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, Czernichow S, Hercberg S.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 01; 14(9):2269-72. PubMed ID: 16172243
    [Abstract] [Full Text] [Related]

  • 19. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug 01; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.
    Wu X, Tortolero-Luna G, Zhao H, Phatak D, Spitz MR, Follen M.
    Clin Cancer Res; 2003 Aug 15; 9(9):3356-61. PubMed ID: 12960122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.